Our Products
Below is a full list of the products marketed and commercialized in the US by OAPI that have been either developed, acquired, or in-licensed by Otsuka. Our product specialties include neuroscience, digital innovation, nephrology, oncology, and medical devices.
Neuroscience
ABILIFY®
(aripiprazole)
ABILIFY ASIMTUFII®
(aripiprazole) for extended release injectable suspension
ABILIFY MAINTENA®
(aripiprazole) for
extended release
injectable suspension
NUEDEXTA®
(dextromethorphan HBr and quinidine sulfate) capsules
REXULTI®
(brexpiprazole)
Digital Innovation
ABILIFY MYCITE®
(aripiprazole tablets with sensor)
Nephrology
JYNARQUE®
(tolvaptan)
SAMSCA®
(tolvaptan)
Oncology
DACOGEN®
(decitabine) for
injection
IV BUSULFEX®
(busulfan)
To report an adverse event or product
quality complaint,
please call: 1-800-438-9927
To discuss a medical inquiry, call 1-800-441-6763
To search for medical information or submit a medical inquiry, please click here